Local anaesthetics are a fundamental pillar of everyday anaesthetic practice for blocking nerve signals effectively and safely. Rational use of these drugs requires a precise understanding of their physicochemical properties, their specific doses, and how to deal immediately with their life-threatening systemic toxicity.
Classification, Metabolism and Risk of Hypersensitivity
Local anaesthetics are structurally divided into two classes: Amides and Esters. The metabolism of Amides depends on the liver and hepatic blood flow, whereas Esters undergo hydrolysis in plasma by the enzyme Pseudocholinesterase. The breakdown of Esters produces para-aminobenzoic acid (PABA), which can trigger allergic reactions in patients. Because Amides do not produce PABA during their hepatic metabolism, true allergic reactions to them are extremely rare.
Physicochemical Properties, Onset and Binding
The speed of onset of a local anaesthetic is inversely related to its pKa value; for example, Lidocaine (pKa 7.9) has a faster onset than Bupivacaine (pKa 8.1), because about 25% of Lidocaine is in the non-ionised form at physiological pH (pH 7.4) compared with only 15% for Bupivacaine. On the other hand, the potency of the anaesthetic is directly proportional to its lipid solubility, although increasing this solubility also raises the likelihood of systemic toxicity. The duration of action is determined by the degree of protein binding, as Amides bind to alpha1-acid glycoprotein and Albumin.
Maximum Doses and the Cardiotoxicity of Bupivacaine
Recommendations set the maximum bolus dose of Lidocaine alone at 200 mg (or 3 mg/kg), which rises to 500 mg (or 7 mg/kg) when Adrenaline is added. The maximum recommended bolus dose of Bupivacaine alone is 150 mg (or 2 mg/kg). The serious cardiotoxicity of Bupivacaine arises from its high lipid solubility and its extensive protein binding of 95%, which causes prolonged blockade of cardiac sodium channels, prolongation of the PR and QRS intervals, ventricular arrhythmias and refractory cardiac arrest, effects that are clearly aggravated in the presence of Acidosis or Hypoxia.
Signs of Systemic Toxicity (LAST) and the Lipid Emulsion Protocol
Systemic toxicity (LAST) is characterised by the central nervous system (CNS) being more sensitive than the myocardium, with symptoms beginning early with perioral numbness, tongue numbness, tinnitus and blurred vision, followed by agitation, tremor, drowsiness, convulsions and respiratory depression, culminating in cardiovascular collapse. Rescue relies on 20% lipid emulsion, given as an intravenous bolus of 1.5 ml/kg over one minute followed by an infusion of 15 ml/kg/hour. If instability persists, the bolus (1.5 ml/kg) is repeated up to twice at 5-minute intervals and the infusion is doubled to 30 ml/kg/hour, provided that the total cumulative dose does not exceed 12 ml/kg.
- Amides are metabolised by the liver, do not produce PABA and rarely cause allergy, unlike Esters, which are broken down in plasma by Pseudocholinesterase and produce PABA, which causes allergy.
- The speed of onset is inversely related to pKa (Lidocaine is faster thanks to 25% being non-ionised at pH 7.4 versus 15% for Bupivacaine).
- Potency is directly proportional to lipid solubility (with increased toxicity), whereas the duration of action is determined by binding to Albumin and alpha1-acid glycoprotein.
- The maximum bolus dose of Lidocaine reaches 200 mg alone (500 mg with Adrenaline), and for Bupivacaine alone 150 mg.
- When instability persists, LAST is treated with boluses of 1.5 ml/kg of 20% lipid emulsion and by doubling the infusion to 30 ml/kg/hour, with a maximum cumulative dose of 12 ml/kg.
Sources
- Smith and Aitkenhead's Textbook of Anaesthesia, 7th ed., p. 94
- Smith and Aitkenhead's Textbook of Anaesthesia, 7th ed., p. 95
- Smith and Aitkenhead's Textbook of Anaesthesia, 7th ed., Table 5.2, p. 95
- Smith and Aitkenhead's Textbook of Anaesthesia, 7th ed., p. 97
- Drugs in Anaesthesia and Intensive Care, 5th ed., p. 199
Test yourself: 7 questions on this topic and many more →
Educational content for healthcare staff and students. It does not replace clinical judgement or your hospital protocol; check any dose against the reference and local guidance before use.